Cite
HARVARD Citation
Pritchard‐Jones, K. et al. (n.d.). Response to the letter to the editor: 1q gain is a frequent finding in preoperatively treated Wilms tumors, but of limited prognostic value for risk satisfaction in the SIOP2009/Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) trial. Genes, chromosomes & cancer. 54 (6), pp. 397-399. [Online].